Toni Ibrahim
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 219 publications
Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358].
Journal: Critical reviews in oncology/hematology
Published: June 27, 2026
Management of atypical cartilaginous tumors (ACT): an Italian Sarcoma Group (ISG) consensus document.
Journal: Critical reviews in oncology/hematology
Published: March 04, 2026
Circulating IGF2BP3 enables risk stratification and predicts treatment response in Ewing sarcoma.
Journal: Scientific reports
Published: February 24, 2026
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 20, 2026
Drug-loaded biomorphic scaffolds for tissue regeneration and targeted antitumor therapy in bone metastasis models.
Journal: Biomaterials advances
Published: February 18, 2026
Editorial Expression of Concern: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
Journal: Nature medicine
Published: February 04, 2026
Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma.
Journal: International journal of molecular sciences
Published: January 18, 2026
Reply to: Mifamurtide in Nonmetastatic High-Grade Osteosarcoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 14, 2026
Light-triggered drug release via fiber optic heater-integrated with thermoresponsive microgels for locoregional cancer therapy.
Journal: Scientific reports
Published: January 13, 2026
Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational study.
Journal: Journal of bone oncology
Published: November 23, 2025
Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center Experience.
Journal: Cancers
Published: November 19, 2025
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort.
Journal: Cancer communications (London, England)
Published: November 13, 2025
Last Updated: 09/26/2026